Collaborations & Alliances

AGC Biologics, RoosterBio Enter Cell and Exosome Therapies Mfg. Pact

Aims to deliver clinically proven products and manufacturing processes for advanced therapies.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), entered a strategic partnership with RoosterBio Inc., a supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services.   The partnership aims to create an end-to-end solution for the development and production of hMSC and exosome therapeutics leveraging RoosterBio’s cell and media products and process development services, coupled with A...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters